Nachrichten zur Merck & Co. Inc. Aktie

Merck & Co., Inc.: Merck: Aiming for Health Equity and Business Success

NORTHAMPTON, MA / ACCESSWIRE / April 6, 2023 / Josette Gbemudu is motivated to ensure everyone has the chance to…

Bayer- und Merck & Co-Aktie im Minus: Bayer siegt über Merck in US-Haftungsstreit um asbesthaltiges Talkum-Puder - Millioneninvestment in Ukraine

Im Streit um die Haftung für Talkum-Puder mit Asbest-Partikeln nach der Übernahme des Konsumgütergeschäfts von Merck konnte der deutsche Pharmariese…

Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?

Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Merck (MRK), Seagen Drug Combo Gets FDA Nod for Bladder Cancer

The combination of Mercks (MRK) Keytruda and Seagens (SGEN) Padcev is the first approved immunotherapy and an antibody-drug conjugate for…

Erfolg vor Gericht: Bayer siegt gegen Merck & Co im Streit um Puder-Haftungsrisiken

Sieg für Bayer im Rechtsstreit mit der US-amerikanischen Merck & Co. Die Amerikaner hatten versucht, Haftungsrisiken an die Leverkusener abzutreten,…

Bayer erzielt einen wichtigen Erfolg in einem Rechtsstreit mit Merck & Co - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Bayer-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie der Bayer AG (ISIN: DE000BAY0017,…

Pharmabranche: Bayer siegt über Merck in US-Haftungsstreit um asbesthaltiges Talkum-Puder

Bayer hatte 2014 das Konsumgütergeschäft des US-Konkurrenten übernommen. Merck & Co hatte versucht, Haftungsrisiken an den Dax-Konzern weiterzugeben – ist…

Merck & Co Unusual Options Activity For March 29

read more...…

Merck & Co: Downgrade

Paris (www.aktiencheck.de) - Rating-Update: Justin Smith, Analyst der Société Générale, stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN:…

Merck & Co., Inc.: Amplifying the Power of Women in Chemistry

NORTHAMPTON, MA / ACCESSWIRE / March 22, 2023 / Merck & Co., Inc. For Dr. Rebecca Ruck, having more women…

Top Research Reports for Merck, Intel & MercadoLibre

Todays Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Intel Corporation (INTC)…

Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?

Strong sales of key products like Keytruda and Gardasil and positive pipeline/regulatory developments should keep Mercks (MRK) stock afloat in…

Studienrückschlag für Merck & Co - FedEx hebt Prognose an - Dividendenkürzung bei Vonovia

Wien (www.aktiencheck.de) - Auf den Papieren des US-Pharmakonzerns Merck & Co (ISIN: US58933Y1055, WKN: A0YD8Q, Ticker-Symbol: 6MK, NYSE-Symbol: MRK) lastete…

Merck’s combination therapy in lung cancer fails a Phase 2 clinical trial

Merck & Co. Inc. MRK said late Thursday that its combination therapy of vibostolimab and Keytruda did not outperform chemotherapy…

Merck & Co: Abstufung und Kurszielsenkung

San Francisco (www.aktiencheck.de) - Rating-Update: Wells Fargo Advisors stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN: A0YD8Q, Ticker-Symbol:…

XETR : DIVIDEND/INTEREST INFORMATION - 14.03.2023 - US58933Y1055

Das Instrument 6MK US58933Y1055 MERCK CO. DL-,01 EQUITY wird ex Dividende/Zinsen…

Merck & Co: Kursziel angehoben

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Guggenheim Securities stufen die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN:…

XFRA : DIVIDEND/INTEREST INFORMATION - 14.03.2023 - US58933Y1055

Das Instrument 6MK US58933Y1055 MERCK CO. DL-,01 EQUITY wird cum Dividende/Zinsen…

Merck: Phase 2/3 CCTG IND.227/KEYNOTE-483 Trial With KEYTRUDA Meets Primary Endpoint

KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) and the Canadian Cancer Trials Group announced that the Phase 2/3 CCTG IND.227/KEYNOTE-483 trial…

Merck (MRK) Reports Detailed Data From PAH Study on Sotatercept

Merck & Co. (MRK) announces detailed data from the phase III STELLAR study of sotatercept for the treatment of pulmonary…

Merck & Co: Anlagevotum bestätigt

New York (www.aktiencheck.de) - Rating-Update: Mara Goldstein, Analystin von Mizuho Securities USA, stuft die Aktie von Merck & Co Inc.…

Mercks MK-0616 Cuts LDL-C in Hypercholesterolemia in Phase 2b Study >MRK

Merck's MK-0616 Cuts LDL-C in Hypercholesterolemia in Phase 2b Study >MRK...…

Merck (MRK) Stock Sinks As Market Gains: What You Should Know

Merck (MRK) closed at $106.88 in the latest trading session, marking a -0.12% move from the prior day....…

Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…

Merck, AstraZeneca say FDA panel to review application for cancer drug

...March 2 (Reuters) - Merck & Co Inc and AstraZeneca PLC said......…

Merck: Phase 3 KEYNOTE-671 Trial With KEYTRUDA Meets One Of Its Dual Primary Endpoints

KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) announced that the Phase 3 KEYNOTE-671 trial investigating KEYTRUDA met one of its dual…

Merck: Phase 3 Keytruda Study Hits Key Goal in Non-Small Cell Lung Cancer >MRK

Merck: Phase 3 Keytruda Study Hits Key Goal in Non-Small Cell Lung Cancer >MRK...…

Merck to discontinue Keytruda combination study for prostate cancer

...(Reuters) - Merck & Co on Tuesday said it will stop a late-stage......…

NVIDIA-Aktie nach Zahlen im Aufwind - Fresenius will sich auf Kerngeschäft konzentrieren

Wien (www.aktiencheck.de) - Als Reaktion auf das Zahlenwerk von Mittwochabend konnte die Aktie von NVIDIA (ISIN: US67066G1040, WKN: 918422, Ticker-Symbol:…

Merck & Co: "overweight"

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von J.P. Morgan Securities stufen die Aktie von Merck & Co Inc. (ISIN:…

Form 10-K Merck & Co., Inc. For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Merck: CHMP Recommends Against Approval Of Lagevrio For Treatment Of Certain Adults With COVID-19

KENILWORTH (NJ) (dpa-AFX) - Merck & Co Inc. (MRK) and Ridgeback Biotherapeutics said Friday that the Committee for Medicinal Products…

Merck: CHMP Recommends Against OK of Lagevrio for Certain Adults With Covid-19 >MRK

Merck: CHMP Recommends Against OK of Lagevrio for Certain Adults With Covid-19 >MRK...…

Merck and Ridgeback Biotherapeutics to appeal advisory panel to EU regulator’s decision to recommend refusing authorization of their COVID antiviral

Merck & Co. Inc. MRK and privately held Ridgeback Biotherapeutics said Friday a panel advising the European regulator has recommended…

Moderna stock pops after cancer-vaccine candidate gets FDA breakthrough designation

Moderna Inc. MRNAand Merck Inc. MRK shares increased in after-hours trading Wednesday after the pharmaceutical companies announced that a cancer-vaccine…

Lung Cancer Drugs Global Market Report 2023

NEW YORK, Feb. 21, 2023 /PRNewswire/ -- Major players in the lung cancer market are Bristol-Myers Squibb Company, Merck &…

Antiglaucoma Drugs Global Market Report 2023

NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Major players in the antiglaucoma drugs market are Aerie Pharmaceuticals, Inc., Allergan, Novartis…

Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?

Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could…

Merck (MRK) Gets Priority Tag for Antiviral Drug Prevymis sNDA

The FDA grants priority review designation to Mercks (MRK) sNDA seeking expanded use of Prevymis. The PDUFA date is Jun…

Moderna fallen nach Studiendaten: Zinssorgen belasten US-Börsen

Die Inflationssorgen lassen die Anleger an der Wall Street zum Wochenschluss nicht los. Der Dow wird unter anderem vom Pharmakonzern…

FDA to Review Two Expansions of Mercks Prevymis >MRK

FDA to Review Two Expansions of Merck's Prevymis >MRK...…

Antiobesity Global Market Report 2023

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the anti-obesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC,…

Insiderhandel: President, Human Health Int?l verkauft Aktien von Merck & Company im Wert von 541.101$

Romanelli, Joseph - Vorstand - Tag der Transaktion: 2023-02-15...…

Insiderhandel: EVP, Chief HR Officer verkauft Aktien von Merck & Company im Wert von 198.017$

Mizell, Steven - Vorstand - Tag der Transaktion: 2023-02-13...…

DTP Vaccines Global Market Report 2023

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the DTP vaccines market are Merck & Co, Sanofi, GSK,…

Merck & Co: Die Konferenz des American College of Cardiology 2023 als ein wichtiger Katalysator? Aktienanalyse

Zürich (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Analyst Trung Huynh von der Credit Suisse: Trung Huynh, Analyst von der Credit Suisse,…

Merck & Co: Solides Ergebnis, aber verhaltener Ausblick - Aktienanalyse

Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der Raiffeisen Bank International AG: Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI),…

Merck & Co: Kursziel angehoben

Charlotte, NC (www.aktiencheck.de) - Rating-Update: Robyn Karnauskas, Analystin von Truist, stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN:…

Insiderhandel: EVP, Chief HR Officer verkauft Aktien von Merck & Company im Wert von 535.007$

Mizell, Steven - Vorstand - Tag der Transaktion: 2023-02-09...…